个人中心 - 老虎社区

wkwkwkwk

IP属地：未知

帖子 · 17帖子 · 17
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- wkwkwkwkwkwkwkwk
  ·2021-09-01
  Will more companies continue to hold virtual meeting?
  ZM Stock Alert: 8 Reasons Why Zoom Video Is Tumbling Today
  Zoom Video Communications(NASDAQ:ZM) stock is taking a beating on Tuesday following the release of t
  ZM Stock Alert: 8 Reasons Why Zoom Video Is Tumbling Today
  619 1
  3
  分享
  举报
- wkwkwkwkwkwkwkwk
  ·2021-09-01
  Please help to like
  非常抱歉，此主贴已删除
  1,931 3
  3
  分享
  举报
- wkwkwkwkwkwkwkwk
  ·2021-08-28
  Anyoneb uying?
  Which Biotech Stock Will Shock the Market in 2022?
  Over the last few years, three tiny biotechs emerged out of nowhere to give amazing returns to early investors. Which biotech might pull off a similar feat in 2022?
  Which Biotech Stock Will Shock the Market in 2022?
  688 评论
  点赞
  分享
  举报
- wkwkwkwkwkwkwkwk
  ·2021-08-28
  Great news
  非常抱歉，此主贴已删除
  1,791 评论
  2
  分享
  举报
- wkwkwkwkwkwkwkwk
  ·2021-08-27
  Interesting. Please help to like too
  非常抱歉，此主贴已删除
  494 评论
  3
  分享
  举报
- wkwkwkwkwkwkwkwk
  ·2021-08-25
  Go go go
  Alphabet shares rose 1.3% to a new high
  Alphabet shares rose 1.3% to a new high. By and large, investors know Alphabet Inc. (GOOGL) as the
  Alphabet shares rose 1.3% to a new high
  789 1
  6
  分享
  举报
- wkwkwkwkwkwkwkwk
  ·2021-08-25
  Like
  Here's Why Visa Is One of the Best Long-Term Stocks to Buy
  The largest payments network is still growing.
  Here's Why Visa Is One of the Best Long-Term Stocks to Buy
  1,330 1
  4
  分享
  举报
- wkwkwkwkwkwkwkwk
  ·2021-08-24
  Please help to like
  Visa jumps into the NFT craze, buying a ‘CryptoPunk’ for $150,000
  KEY POINTS Visa said Monday it bought a “CryptoPunk,” one of thousands of NFT-based digital avatars
  Visa jumps into the NFT craze, buying a ‘CryptoPunk’ for $150,000
  1,838 评论
  点赞
  分享
  举报
- wkwkwkwkwkwkwkwk
  ·2021-08-22
  Great news. Please help to like
  非常抱歉，此主贴已删除
  1,538 评论
  4
  分享
  举报
- wkwkwkwkwkwkwkwk
  ·2021-08-14
  Will take a look
  2 Tech Stocks With 96% to 140% Upside, According to Wall Street
  Analysts see big gains for Coinbase and Lemonade shareholders.
  2 Tech Stocks With 96% to 140% Upside, According to Wall Street
  720 评论
  2
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3582032677933516","uuid":"3582032677933516","gmtCreate":1618941710686,"gmtModify":1618941710686,"name":"wkwkwkwk","pinyin":"wkwkwkwk","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":5,"tweetSize":17,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":818440405,"gmtCreate":1630435416807,"gmtModify":1633678108868,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Will more companies continue to hold virtual meeting?","listText":"Will more companies continue to hold virtual meeting?","text":"Will more companies continue to hold virtual meeting?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/818440405","repostId":"1155259610","repostType":4,"repost":{"id":"1155259610","kind":"news","pubTimestamp":1630421174,"share":"https://ttm.financial/m/news/1155259610?lang=&edition=full","pubTime":"2021-08-31 22:46","market":"us","language":"en","title":"ZM Stock Alert: 8 Reasons Why Zoom Video Is Tumbling Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1155259610","media":"investorplace","summary":"Zoom Video Communications(NASDAQ:ZM) stock is taking a beating on Tuesday following the release of t","content":"<p><b>Zoom Video Communications</b>(NASDAQ:<b><u>ZM</u></b>) stock is taking a beating on Tuesday following the release of the company’s earnings report for the second quarter of fiscal 2022.</p>\n<p>Let’s dive into that earnings report below to see what has ZM stock falling today.</p>\n<ul>\n <li>The biggest problem facing Zoom Video this morning is its guidance for the upcoming quarter.</li>\n <li>That begins with an outlook for Q3 that includes&nbsp;adjusted earnings per share of $1.07 to $1.08.</li>\n <li>This would have it missing Wall Street’s estimate of $1.09 for the quarter.</li>\n <li>There’s also the fact that Zoom Video is seeing slower growth now that lockdowns are coming to an end.</li>\n <li>That’s a result of schools and businesses using the company’s services less and less to hold virtual meetings.</li>\n <li>These are pulling down an otherwise solid earnings report for the company.</li>\n <li>Its adjusted earnings per share for the current quarter was $1.36, which beat out Wall Street’s estimate of $1.16.</li>\n <li>Revenue of $1.02 billion was also better than the $990.96 million that analysts were expecting.</li>\n</ul>\n<p>Eric Yuan, founder and CEO of Zoom Video, said the following in the earnings report affecting ZM stock today.</p>\n<blockquote>\n “In Q2, we achieved our first billion dollar revenue quarter while delivering strong profitability and cash flow. Q2 also marked several milestones on our expansion beyond the UC platform. We launched Zoom Apps, bringing over 50 apps directly into the Zoom experience, and Zoom Events, an all-in-one digital events service.”\n</blockquote>\n<p>It’s also worth pointing out that ZM stock is seeing heavy trading alongside this news. As of this writing, more than 15 million shares of the stock have changed hands. That’s a significant increase over its daily average trading volume of about 3.2 million shares.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ZM Stock Alert: 8 Reasons Why Zoom Video Is Tumbling Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZM Stock Alert: 8 Reasons Why Zoom Video Is Tumbling Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-31 22:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/08/zm-stock-alert-8-reasons-why-zoom-video-is-tumbling-today/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Zoom Video Communications(NASDAQ:ZM) stock is taking a beating on Tuesday following the release of the company’s earnings report for the second quarter of fiscal 2022.\nLet’s dive into that earnings ...</p>\n\n<a href=\"https://investorplace.com/2021/08/zm-stock-alert-8-reasons-why-zoom-video-is-tumbling-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZM":"Zoom"},"source_url":"https://investorplace.com/2021/08/zm-stock-alert-8-reasons-why-zoom-video-is-tumbling-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155259610","content_text":"Zoom Video Communications(NASDAQ:ZM) stock is taking a beating on Tuesday following the release of the company’s earnings report for the second quarter of fiscal 2022.\nLet’s dive into that earnings report below to see what has ZM stock falling today.\n\nThe biggest problem facing Zoom Video this morning is its guidance for the upcoming quarter.\nThat begins with an outlook for Q3 that includes adjusted earnings per share of $1.07 to $1.08.\nThis would have it missing Wall Street’s estimate of $1.09 for the quarter.\nThere’s also the fact that Zoom Video is seeing slower growth now that lockdowns are coming to an end.\nThat’s a result of schools and businesses using the company’s services less and less to hold virtual meetings.\nThese are pulling down an otherwise solid earnings report for the company.\nIts adjusted earnings per share for the current quarter was $1.36, which beat out Wall Street’s estimate of $1.16.\nRevenue of $1.02 billion was also better than the $990.96 million that analysts were expecting.\n\nEric Yuan, founder and CEO of Zoom Video, said the following in the earnings report affecting ZM stock today.\n\n “In Q2, we achieved our first billion dollar revenue quarter while delivering strong profitability and cash flow. Q2 also marked several milestones on our expansion beyond the UC platform. We launched Zoom Apps, bringing over 50 apps directly into the Zoom experience, and Zoom Events, an all-in-one digital events service.”\n\nIt’s also worth pointing out that ZM stock is seeing heavy trading alongside this news. As of this writing, more than 15 million shares of the stock have changed hands. That’s a significant increase over its daily average trading volume of about 3.2 million shares.","news_type":1,"symbols_score_info":{"ZM":0.9}},"isVote":1,"tweetType":1,"viewCount":619,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818440623,"gmtCreate":1630435284462,"gmtModify":1633678109093,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Please help to like","listText":"Please help to like","text":"Please help to like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/818440623","repostId":"1173998132","repostType":4,"isVote":1,"tweetType":1,"viewCount":1931,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819489817,"gmtCreate":1630087728639,"gmtModify":1704955826188,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Anyoneb uying?","listText":"Anyoneb uying?","text":"Anyoneb uying?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819489817","repostId":"2162602132","repostType":4,"repost":{"id":"2162602132","kind":"highlight","pubTimestamp":1630076857,"share":"https://ttm.financial/m/news/2162602132?lang=&edition=full","pubTime":"2021-08-27 23:07","market":"us","language":"en","title":"Which Biotech Stock Will Shock the Market in 2022?","url":"https://stock-news.laohu8.com/highlight/detail?id=2162602132","media":"Motley Fool","summary":"Over the last few years, three tiny biotechs emerged out of nowhere to give amazing returns to early investors. Which biotech might pull off a similar feat in 2022?","content":"<p>In 2019, tiny&nbsp;<b><a href=\"https://laohu8.com/S/AXSM\">Axsome Therapeutics</a>&nbsp;</b>(NASDAQ:AXSM) emerged from micro-cap obscurity to become the best-performing stock in the market, rising by an amazing 3,600% in a year. In 2020, another tiny biotech,&nbsp;<b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a>&nbsp;</b>(NASDAQ:NVAX), came out of nowhere to stomp the stock market, with its share price skyrocketing by 2,700%. For most of 2021, yet another small biotech has been the top-performing stock in the market, as&nbsp;<b><a href=\"https://laohu8.com/S/SAVA\">Cassava Sciences Inc</a> </b>(NASDAQ:SAVA) jumped from under $7 a share in January to $123 a share on Aug. 24. (Whether it will keep its lead is another question, as the volatility is savage -- the stock is down to $52 as of Friday morning after news of a citizen petition against the company.)</p>\n<p>What's fascinating about the biotech sector in particular is how fast it moves. The sector is notorious for amazing price swings -- in either direction -- that can happen overnight. So why is that? Why are biotech stocks in particular so volatile? Why do they keep leading the market every year? And what biotech stock might -- repeat, <i>might&nbsp;</i>-- pull off this feat next year? Let's analyze why Axsome, Novavax, and Cassava zoomed higher over the last few years, and why I think <b><a href=\"https://laohu8.com/S/PIRS\">Pieris Pharmaceuticals</a> </b>(NASDAQ:PIRS) has a chance at a similar remarkable performance in 2022.</p>\n<p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F638648%2Fgettyimages-108224060.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"465\" referrerpolicy=\"no-referrer\"></p>\n<h2>Biotech winners tend to start off tiny</h2>\n<p>The main reason these stocks were able to soar so impressively is that all three started with very tiny market caps. At the end of 2018, Axsome Therapeutics had a micro-cap valuation of $85 million. In 2019, Novavax stock fell to below $1, and the company had to do a 1-for-20 reverse split in order to keep its shares listed on the <b><a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a></b>. And at the beginning of 2020, Cassava had barely achieved small-cap status, with its market cap hovering at $240 million.</p>\n<p>So all three barn-burning stocks started off unloved by the market. Why does a biotech stock get so cheap? Probably the most common reason is the market believes the company's science is bad. Novavax, for instance, had a notable failure in its quest for a respiratory syncytial virus (RSV) vaccine. This clinical trial failure sent investors to the exits and sent the stock down into a crater in 2019, when it plunged to $4 a share (or $0.20 pre-split).</p>\n<p>Yet the market was spectacularly wrong about Novavax. While the company's RSV drug was a failure, Novavax had another drug in clinical trials, a flu vaccine. And this drug was a world-beater. It was flying through clinical trials, and it had defeated the market-leading flu vaccines from <b><a href=\"https://laohu8.com/S/SNY\">Sanofi SA</a></b>&nbsp;(NASDAQ:SNY) over and over again.</p>\n<p>In 2019, Novavax had the label of \"bad science,\" but the data for a different drug said otherwise. Sometimes companies with tiny market caps actually have compelling drugs that are performing exceptionally well in clinical trials. If you find such a company, you might want to buy some shares.</p>\n<h2>Is there enough money for a phase 3 trial?</h2>\n<p>That said, it's not enough just to have good science. Nobody is allowed to market their drugs to the public until that science has been validated in clinical trials and approved by the U.S. Food and Drug Administration -- and clinical trials cost a huge amount of money. Thus, before investing, it's important to determine whether the biotech has enough cash for a phase 3 trial. If the answer is \"no,\" the drug is stalled and won't go anywhere.</p>\n<p>Many unprofitable biotech companies finesse the money issue by collaborating with Big Pharma. When you see such a collaboration, you can have faith that there's enough cash for a phase 3 trial. However, these arrangements also often mean that the bigger pharmaceutical company acquires the rights to the molecule. And that can be like like selling off your future in order to pay the bills today.</p>\n<p>Interestingly, neither Axsome nor Novavax nor Cassava have an active collaboration with any big-pharma leaders. Instead, all three of these companies have elected to own 100% of the rights to their lead molecules. While the median expense for a phase 3 trial is $19 million, the numbers can vary dramatically, depending on how large the patient population is. I'd be nervous if a biotech had less than $100 million in cash (each of these has more). There's no question this independent approach is riskier, but also potentially a lot more rewarding.</p>\n<p>Biotech investors often like to see collaboration with Big Pharma -- it's a validation of the science, and it removes a lot of financial worries for small companies. But if you're chasing big rewards, you might want to look at biotech companies that are still independent (and have enough cash to stay that way).</p>\n<h2>Can Pieris pull off a miracle run in 2022?</h2>\n<p>Pieris stock is very cheap right now, with a $291 million valuation. (You know a stock is cheap when it could have a 10-bagger and still qualify as a small-cap!) Is the stock so cheap because its science is bad?</p>\n<p>It would probably be more accurate to say that Pieris' science is unproven. Like many unprofitable biotechs, Pieris doesn't have a drug in phase 3 trials yet. In fact, we're still waiting on positive phase 2 data. So it's early, and that's a danger sign. The reason Axsome, Novavax, and Cassava all skyrocketed is that all three companies made the journey from unproven drug to pivotal trials very quickly. Pieris is a few years away.</p>\n<p>Another major difference is that Pieris has signed multiple collaborative deals -- with <b>Roche</b>, <b>AstraZeneca</b>, and <b>Seagen</b>, among others. In <a href=\"https://laohu8.com/S/AONE.U\">one</a> sense that's good news, because it means that money for clinical trials isn't an issue for the company. Any drugs that work will make it to phase 3 trials and beyond. And all this collaboration adds confidence that the company is on the right track.</p>\n<p>Is Pieris sacrificing its future to pay for its present? In my opinion, no. While AstraZeneca now has rights to the company's asthma drug (its lead molecule), what makes Pieris such an exciting stock is not <a href=\"https://laohu8.com/S/AONE.U\">one</a> particular drug, but the company's entire platform. Pieris owns the rights to all the Anticalin proteins, and its library contains more than 100 billion of these new molecules. Anticalins are much smaller than antibodies, and as such can go where antibodies cannot. AstraZeneca paid big bucks for the rights to Pieris' asthma drug because that Anticalin molecule is small enough to go directly to the lung.</p>\n<p>I love the risk/reward equation for Pieris. If the company's drugs actually work -- we'll have data in that regard next year -- the stock will shoot much higher. Under its existing collaboration agreements, Pieris might make up to $9 billion if its Anticalin drugs reach certain milestones.&nbsp;But what will really make the stock take off is if/when other pharmaceutical players start making deals to add some of the company's Anticalin molecules to their pipelines.</p>\n<p>How do you value an entire new class of pharmaceuticals? Well, in 2019, worldwide sales for monoclonal antibodies (mAbs) totaled <i>$163 billion</i>. If Pieris' partners report any positive data on its Anticalin drugs next year, the upside for this stock is enormous.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Which Biotech Stock Will Shock the Market in 2022?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhich Biotech Stock Will Shock the Market in 2022?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 23:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/27/which-biotech-stock-will-shock-the-market-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In 2019, tiny Axsome Therapeutics (NASDAQ:AXSM) emerged from micro-cap obscurity to become the best-performing stock in the market, rising by an amazing 3,600% in a year. In 2020, another tiny biotech...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/27/which-biotech-stock-will-shock-the-market-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AXSM":"Axsome Therapeutics, Inc.","SAVA":"Cassava Sciences Inc","NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.fool.com/investing/2021/08/27/which-biotech-stock-will-shock-the-market-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162602132","content_text":"In 2019, tiny Axsome Therapeutics (NASDAQ:AXSM) emerged from micro-cap obscurity to become the best-performing stock in the market, rising by an amazing 3,600% in a year. In 2020, another tiny biotech, Novavax (NASDAQ:NVAX), came out of nowhere to stomp the stock market, with its share price skyrocketing by 2,700%. For most of 2021, yet another small biotech has been the top-performing stock in the market, as Cassava Sciences Inc (NASDAQ:SAVA) jumped from under $7 a share in January to $123 a share on Aug. 24. (Whether it will keep its lead is another question, as the volatility is savage -- the stock is down to $52 as of Friday morning after news of a citizen petition against the company.)\nWhat's fascinating about the biotech sector in particular is how fast it moves. The sector is notorious for amazing price swings -- in either direction -- that can happen overnight. So why is that? Why are biotech stocks in particular so volatile? Why do they keep leading the market every year? And what biotech stock might -- repeat, might -- pull off this feat next year? Let's analyze why Axsome, Novavax, and Cassava zoomed higher over the last few years, and why I think Pieris Pharmaceuticals (NASDAQ:PIRS) has a chance at a similar remarkable performance in 2022.\n\nBiotech winners tend to start off tiny\nThe main reason these stocks were able to soar so impressively is that all three started with very tiny market caps. At the end of 2018, Axsome Therapeutics had a micro-cap valuation of $85 million. In 2019, Novavax stock fell to below $1, and the company had to do a 1-for-20 reverse split in order to keep its shares listed on the Nasdaq. And at the beginning of 2020, Cassava had barely achieved small-cap status, with its market cap hovering at $240 million.\nSo all three barn-burning stocks started off unloved by the market. Why does a biotech stock get so cheap? Probably the most common reason is the market believes the company's science is bad. Novavax, for instance, had a notable failure in its quest for a respiratory syncytial virus (RSV) vaccine. This clinical trial failure sent investors to the exits and sent the stock down into a crater in 2019, when it plunged to $4 a share (or $0.20 pre-split).\nYet the market was spectacularly wrong about Novavax. While the company's RSV drug was a failure, Novavax had another drug in clinical trials, a flu vaccine. And this drug was a world-beater. It was flying through clinical trials, and it had defeated the market-leading flu vaccines from Sanofi SA (NASDAQ:SNY) over and over again.\nIn 2019, Novavax had the label of \"bad science,\" but the data for a different drug said otherwise. Sometimes companies with tiny market caps actually have compelling drugs that are performing exceptionally well in clinical trials. If you find such a company, you might want to buy some shares.\nIs there enough money for a phase 3 trial?\nThat said, it's not enough just to have good science. Nobody is allowed to market their drugs to the public until that science has been validated in clinical trials and approved by the U.S. Food and Drug Administration -- and clinical trials cost a huge amount of money. Thus, before investing, it's important to determine whether the biotech has enough cash for a phase 3 trial. If the answer is \"no,\" the drug is stalled and won't go anywhere.\nMany unprofitable biotech companies finesse the money issue by collaborating with Big Pharma. When you see such a collaboration, you can have faith that there's enough cash for a phase 3 trial. However, these arrangements also often mean that the bigger pharmaceutical company acquires the rights to the molecule. And that can be like like selling off your future in order to pay the bills today.\nInterestingly, neither Axsome nor Novavax nor Cassava have an active collaboration with any big-pharma leaders. Instead, all three of these companies have elected to own 100% of the rights to their lead molecules. While the median expense for a phase 3 trial is $19 million, the numbers can vary dramatically, depending on how large the patient population is. I'd be nervous if a biotech had less than $100 million in cash (each of these has more). There's no question this independent approach is riskier, but also potentially a lot more rewarding.\nBiotech investors often like to see collaboration with Big Pharma -- it's a validation of the science, and it removes a lot of financial worries for small companies. But if you're chasing big rewards, you might want to look at biotech companies that are still independent (and have enough cash to stay that way).\nCan Pieris pull off a miracle run in 2022?\nPieris stock is very cheap right now, with a $291 million valuation. (You know a stock is cheap when it could have a 10-bagger and still qualify as a small-cap!) Is the stock so cheap because its science is bad?\nIt would probably be more accurate to say that Pieris' science is unproven. Like many unprofitable biotechs, Pieris doesn't have a drug in phase 3 trials yet. In fact, we're still waiting on positive phase 2 data. So it's early, and that's a danger sign. The reason Axsome, Novavax, and Cassava all skyrocketed is that all three companies made the journey from unproven drug to pivotal trials very quickly. Pieris is a few years away.\nAnother major difference is that Pieris has signed multiple collaborative deals -- with Roche, AstraZeneca, and Seagen, among others. In one sense that's good news, because it means that money for clinical trials isn't an issue for the company. Any drugs that work will make it to phase 3 trials and beyond. And all this collaboration adds confidence that the company is on the right track.\nIs Pieris sacrificing its future to pay for its present? In my opinion, no. While AstraZeneca now has rights to the company's asthma drug (its lead molecule), what makes Pieris such an exciting stock is not one particular drug, but the company's entire platform. Pieris owns the rights to all the Anticalin proteins, and its library contains more than 100 billion of these new molecules. Anticalins are much smaller than antibodies, and as such can go where antibodies cannot. AstraZeneca paid big bucks for the rights to Pieris' asthma drug because that Anticalin molecule is small enough to go directly to the lung.\nI love the risk/reward equation for Pieris. If the company's drugs actually work -- we'll have data in that regard next year -- the stock will shoot much higher. Under its existing collaboration agreements, Pieris might make up to $9 billion if its Anticalin drugs reach certain milestones. But what will really make the stock take off is if/when other pharmaceutical players start making deals to add some of the company's Anticalin molecules to their pipelines.\nHow do you value an entire new class of pharmaceuticals? Well, in 2019, worldwide sales for monoclonal antibodies (mAbs) totaled $163 billion. If Pieris' partners report any positive data on its Anticalin drugs next year, the upside for this stock is enormous.","news_type":1,"symbols_score_info":{"AXSM":0.9,"NVAX":0.9,"PIRS":0.9,"SAVA":0.9}},"isVote":1,"tweetType":1,"viewCount":688,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819480291,"gmtCreate":1630087550113,"gmtModify":1704955825153,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Great news","listText":"Great news","text":"Great news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819480291","repostId":"1123342356","repostType":4,"isVote":1,"tweetType":1,"viewCount":1791,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810476834,"gmtCreate":1629999498828,"gmtModify":1704954431941,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Interesting. Please help to like too","listText":"Interesting. Please help to like too","text":"Interesting. Please help to like too","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/810476834","repostId":"2162018921","repostType":4,"isVote":1,"tweetType":1,"viewCount":494,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":834706889,"gmtCreate":1629826611441,"gmtModify":1633682165778,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Go go go","listText":"Go go go","text":"Go go go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/834706889","repostId":"1118949007","repostType":4,"repost":{"id":"1118949007","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1629815206,"share":"https://ttm.financial/m/news/1118949007?lang=&edition=full","pubTime":"2021-08-24 22:26","market":"us","language":"en","title":"Alphabet shares rose 1.3% to a new high","url":"https://stock-news.laohu8.com/highlight/detail?id=1118949007","media":"Tiger Newspress","summary":"Alphabet shares rose 1.3% to a new high.\n\nBy and large, investors know Alphabet Inc. (GOOGL) as the ","content":"<p>Alphabet shares rose 1.3% to a new high.</p>\n<p><img src=\"https://static.tigerbbs.com/ab79065de74f4b0228bb6a8dd5a1ec02\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>By and large, investors know Alphabet Inc. (<b>GOOGL</b>) as the parent company of the search engine that everybody and their uncle uses: Google. I am definitely bullish on GOOGL stock.</p>\n<p>Amazingly, the Google search portal is so famous that in the popular lexicon, “Google” is both a noun and a verb.</p>\n<p>It’s perfectly fine to invest in GOOGL stock because so many people use the company’s search engine. However, stock traders might also choose to look at other angles when considering an investment.</p>\n<p>As we’ll see, the stock could actually be considered a bargain. Moreover, Google’s products give customers what they want: the latest in cutting-edge communications technology.</p>\n<p><b>A Quick Look at GOOGL Stock</b></p>\n<p>At first glance, it might seem ridiculous to say that GOOGL stock is cheap. After all, this is a stock that costs nearly $3,000 per share.</p>\n<p>Moreover, GOOGL stock reached a new 52-week high of $2,817.49 on Monday. It has steadily gone up over the past year, with hardly any breaks or corrections.</p>\n<p>That should be fine for momentum-focused traders, but value-oriented investors might think that GOOGL stock is too expensive to buy now.</p>\n<p>Yet, let’s consider a different angle. If the company’s earnings are robust, then the high price tag of the stock might be fully justified.</p>\n<p>As it turns out, Alphabet’s trailing 12-month price-to-earnings ratio is 30.5. That’s not too bad, especially for a technology stock in 2021.</p>\n<p>So, just maybe, GOOGL stock is still a bargain after all.</p>\n<p><b>Meet the New Google Meet</b></p>\n<p>If you’re going to take away anything from this, it should be that there’s more to Google than its search engine.</p>\n<p>One example would be Google Meet, the company’s video-conferencing software.</p>\n<p>Without a doubt, Google would like to capture a bigger share of the visual-communication software market.<i>Fortune Business Insights</i>reported that this market was worth $5.77 billion in 2020.</p>\n<p>Furthermore, this market is projected to reach $6.28 billion in 2021, and $12.99 billion in 2028, thereby exhibiting a CAGR of 10.9% from 2021 to 2028.</p>\n<p>Google Meet’s new features should help the company take a bigger slice of this rich pie.</p>\n<p>The new features include the ability to add up to 25 co-hosts for meetings. Furthermore, hosts and co-hosts will be able to limit the number of users who can share screens, send messages, and mute others.</p>\n<p><b>An Affordable Smartphone</b></p>\n<p>Let’s face it: not everyone is ready to buy a $1,200 smartphone.</p>\n<p>At the same time, people want high quality. Now, with the launch of the Google Pixel 5a, shoppers don’t have to compromise quality or affordability.</p>\n<p>Granted, Google already unveiled its Pixel 6 and Pixel Pro smartphones, but those are high-end and pricier. There’s a market for lower-priced smartphones, and Google is aggressively pursuing this market with the Pixel 5a.</p>\n<p>We’re talking about a $449 price tag, which is less than half the price of the most expensive smartphones on the market today.</p>\n<p>Some of the phone’s features include 5G functionality, a dual-camera system, and IP67 water and dust resistance.</p>\n<p><b>Wall Street Weighs In</b></p>\n<p>According to TipRanks’ analyst rating consensus, GOOGL is a Strong Buy, based on 29 unanimous Buy ratings. The&nbsp;average Alphabet price target&nbsp;is $3,176.18, implying 13.4% upside potential.</p>\n<p><img src=\"https://static.tigerbbs.com/28be6712f40ae45fa1c1ca53a6200ce0\" tg-width=\"1536\" tg-height=\"580\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p></p>\n<p></p>\n<p><b>Takeaways</b></p>\n<p>While GOOGL stock might seem expensive — and there’s no denying that it’s pricey — a valuation analysis reveals that it’s also a pretty good bargain.</p>\n<p>Just as importantly, Alphabet shouldn’t be pigeonholed as just a search-engine provider.</p>\n<p>The company is expanding quickly into other value-added markets with intriguing products and services, which prospective investors should take into consideration.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alphabet shares rose 1.3% to a new high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlphabet shares rose 1.3% to a new high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-24 22:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Alphabet shares rose 1.3% to a new high.</p>\n<p><img src=\"https://static.tigerbbs.com/ab79065de74f4b0228bb6a8dd5a1ec02\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>By and large, investors know Alphabet Inc. (<b>GOOGL</b>) as the parent company of the search engine that everybody and their uncle uses: Google. I am definitely bullish on GOOGL stock.</p>\n<p>Amazingly, the Google search portal is so famous that in the popular lexicon, “Google” is both a noun and a verb.</p>\n<p>It’s perfectly fine to invest in GOOGL stock because so many people use the company’s search engine. However, stock traders might also choose to look at other angles when considering an investment.</p>\n<p>As we’ll see, the stock could actually be considered a bargain. Moreover, Google’s products give customers what they want: the latest in cutting-edge communications technology.</p>\n<p><b>A Quick Look at GOOGL Stock</b></p>\n<p>At first glance, it might seem ridiculous to say that GOOGL stock is cheap. After all, this is a stock that costs nearly $3,000 per share.</p>\n<p>Moreover, GOOGL stock reached a new 52-week high of $2,817.49 on Monday. It has steadily gone up over the past year, with hardly any breaks or corrections.</p>\n<p>That should be fine for momentum-focused traders, but value-oriented investors might think that GOOGL stock is too expensive to buy now.</p>\n<p>Yet, let’s consider a different angle. If the company’s earnings are robust, then the high price tag of the stock might be fully justified.</p>\n<p>As it turns out, Alphabet’s trailing 12-month price-to-earnings ratio is 30.5. That’s not too bad, especially for a technology stock in 2021.</p>\n<p>So, just maybe, GOOGL stock is still a bargain after all.</p>\n<p><b>Meet the New Google Meet</b></p>\n<p>If you’re going to take away anything from this, it should be that there’s more to Google than its search engine.</p>\n<p>One example would be Google Meet, the company’s video-conferencing software.</p>\n<p>Without a doubt, Google would like to capture a bigger share of the visual-communication software market.<i>Fortune Business Insights</i>reported that this market was worth $5.77 billion in 2020.</p>\n<p>Furthermore, this market is projected to reach $6.28 billion in 2021, and $12.99 billion in 2028, thereby exhibiting a CAGR of 10.9% from 2021 to 2028.</p>\n<p>Google Meet’s new features should help the company take a bigger slice of this rich pie.</p>\n<p>The new features include the ability to add up to 25 co-hosts for meetings. Furthermore, hosts and co-hosts will be able to limit the number of users who can share screens, send messages, and mute others.</p>\n<p><b>An Affordable Smartphone</b></p>\n<p>Let’s face it: not everyone is ready to buy a $1,200 smartphone.</p>\n<p>At the same time, people want high quality. Now, with the launch of the Google Pixel 5a, shoppers don’t have to compromise quality or affordability.</p>\n<p>Granted, Google already unveiled its Pixel 6 and Pixel Pro smartphones, but those are high-end and pricier. There’s a market for lower-priced smartphones, and Google is aggressively pursuing this market with the Pixel 5a.</p>\n<p>We’re talking about a $449 price tag, which is less than half the price of the most expensive smartphones on the market today.</p>\n<p>Some of the phone’s features include 5G functionality, a dual-camera system, and IP67 water and dust resistance.</p>\n<p><b>Wall Street Weighs In</b></p>\n<p>According to TipRanks’ analyst rating consensus, GOOGL is a Strong Buy, based on 29 unanimous Buy ratings. The&nbsp;average Alphabet price target&nbsp;is $3,176.18, implying 13.4% upside potential.</p>\n<p><img src=\"https://static.tigerbbs.com/28be6712f40ae45fa1c1ca53a6200ce0\" tg-width=\"1536\" tg-height=\"580\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p></p>\n<p></p>\n<p><b>Takeaways</b></p>\n<p>While GOOGL stock might seem expensive — and there’s no denying that it’s pricey — a valuation analysis reveals that it’s also a pretty good bargain.</p>\n<p>Just as importantly, Alphabet shouldn’t be pigeonholed as just a search-engine provider.</p>\n<p>The company is expanding quickly into other value-added markets with intriguing products and services, which prospective investors should take into consideration.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GOOGL":"谷歌A","GOOG":"谷歌"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118949007","content_text":"Alphabet shares rose 1.3% to a new high.\n\nBy and large, investors know Alphabet Inc. (GOOGL) as the parent company of the search engine that everybody and their uncle uses: Google. I am definitely bullish on GOOGL stock.\nAmazingly, the Google search portal is so famous that in the popular lexicon, “Google” is both a noun and a verb.\nIt’s perfectly fine to invest in GOOGL stock because so many people use the company’s search engine. However, stock traders might also choose to look at other angles when considering an investment.\nAs we’ll see, the stock could actually be considered a bargain. Moreover, Google’s products give customers what they want: the latest in cutting-edge communications technology.\nA Quick Look at GOOGL Stock\nAt first glance, it might seem ridiculous to say that GOOGL stock is cheap. After all, this is a stock that costs nearly $3,000 per share.\nMoreover, GOOGL stock reached a new 52-week high of $2,817.49 on Monday. It has steadily gone up over the past year, with hardly any breaks or corrections.\nThat should be fine for momentum-focused traders, but value-oriented investors might think that GOOGL stock is too expensive to buy now.\nYet, let’s consider a different angle. If the company’s earnings are robust, then the high price tag of the stock might be fully justified.\nAs it turns out, Alphabet’s trailing 12-month price-to-earnings ratio is 30.5. That’s not too bad, especially for a technology stock in 2021.\nSo, just maybe, GOOGL stock is still a bargain after all.\nMeet the New Google Meet\nIf you’re going to take away anything from this, it should be that there’s more to Google than its search engine.\nOne example would be Google Meet, the company’s video-conferencing software.\nWithout a doubt, Google would like to capture a bigger share of the visual-communication software market.Fortune Business Insightsreported that this market was worth $5.77 billion in 2020.\nFurthermore, this market is projected to reach $6.28 billion in 2021, and $12.99 billion in 2028, thereby exhibiting a CAGR of 10.9% from 2021 to 2028.\nGoogle Meet’s new features should help the company take a bigger slice of this rich pie.\nThe new features include the ability to add up to 25 co-hosts for meetings. Furthermore, hosts and co-hosts will be able to limit the number of users who can share screens, send messages, and mute others.\nAn Affordable Smartphone\nLet’s face it: not everyone is ready to buy a $1,200 smartphone.\nAt the same time, people want high quality. Now, with the launch of the Google Pixel 5a, shoppers don’t have to compromise quality or affordability.\nGranted, Google already unveiled its Pixel 6 and Pixel Pro smartphones, but those are high-end and pricier. There’s a market for lower-priced smartphones, and Google is aggressively pursuing this market with the Pixel 5a.\nWe’re talking about a $449 price tag, which is less than half the price of the most expensive smartphones on the market today.\nSome of the phone’s features include 5G functionality, a dual-camera system, and IP67 water and dust resistance.\nWall Street Weighs In\nAccording to TipRanks’ analyst rating consensus, GOOGL is a Strong Buy, based on 29 unanimous Buy ratings. The average Alphabet price target is $3,176.18, implying 13.4% upside potential.\n\n\n\nTakeaways\nWhile GOOGL stock might seem expensive — and there’s no denying that it’s pricey — a valuation analysis reveals that it’s also a pretty good bargain.\nJust as importantly, Alphabet shouldn’t be pigeonholed as just a search-engine provider.\nThe company is expanding quickly into other value-added markets with intriguing products and services, which prospective investors should take into consideration.","news_type":1,"symbols_score_info":{"GOOG":0.9,"GOOGL":0.9}},"isVote":1,"tweetType":1,"viewCount":789,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":834701017,"gmtCreate":1629826015139,"gmtModify":1633682167032,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/834701017","repostId":"2161818081","repostType":4,"repost":{"id":"2161818081","kind":"highlight","pubTimestamp":1629819036,"share":"https://ttm.financial/m/news/2161818081?lang=&edition=full","pubTime":"2021-08-24 23:30","market":"us","language":"en","title":"Here's Why Visa Is One of the Best Long-Term Stocks to Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2161818081","media":"Motley Fool","summary":"The largest payments network is still growing.","content":"<p>If you're like millions of people, you've already used your <b><a href=\"https://laohu8.com/S/V\">Visa</a></b>&nbsp;(NYSE:V) card today. And that reach is what makes Visa stand out as a business investors want to be a part of.</p>\n<p>The payment network took a big hit during the early stages of the pandemic, when consumer spending plunged. But it's rebounding along with the economy, and that's where its strength lies. As the largest credit card network in the world, it makes money whenever you swipe your card, making this blue-chip company a surefire bet for long-term growth.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F636551%2Fgettyimages-1331306883.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Powering payments</h2>\n<p>Visa's network facilitates payments from consumers to merchants and takes a small fee from each transaction. The sheer number of people who use Visa credit cards demonstrates the company's dominance in the market -- there are currently 3.6 billion Visa cards in use, which translates into almost half the world's population. In 2019, Visa processed more than 200 billion transactions, or more than $11 trillion in volume.</p>\n<p>Because Visa's model is a platform, it's a high-margin business that easily turns sales into profits. Operating margin was over 66% in Q3, and Visa turned $6.1 billion in revenue into $2.6 billion in net income. It also produced more than $4 billion in free cash flow, which it uses to grow its business as well as pay dividends and repurchase stock.</p>\n<p>Business plummeted during the height of pandemic restrictions, but the recovery is moving along. Revenue for the company's fiscal third quarter, covering the period ended June 30, increased 27% from the same period in 2020, but&nbsp; 10% over pre-pandemic 2019 levels.</p>\n<p>Because the pandemic was such an outlier, we can see Visa's strength more clearly in its long-term growth. As of the latest quarter, Visa has grown revenue by a 9.5%&nbsp;compound annual growth rate (CAGR) over the past five years, and net income by an even better rate of 14.3%.</p>\n<h2>Fintech revolution</h2>\n<p>One of the ways Visa is protecting its top spot in credit card processing is acquiring and making deals with fintech partners. Its proposed acquisition of Plaid, a private company that connects financial apps with institutions, was scrapped after it was given a no-go by regulators. But it's made many smaller acquisitions to grow its business and especially to stay relevant as digital payments become more important. Most recently, it acquired Currencycloud, an app that simplifies foreign exchange to make cross-border payments easier. In Q3, it also announced that it would acquire Tink, a Swedish-based open banking platform.</p>\n<p>Visa needs to upgrade its systems as companies like <b><a href=\"https://laohu8.com/S/PYPL\">PayPal</a> Holdings</b>&nbsp;make it easier to send and spend money digitally. Contactless payments are increasing in popularity, and in the U.S. alone Visa customers have more than 370 million tap-to-pay cards. Installment plans have also taken off, with companies such as <b>Afterpay</b>&nbsp;(recently acquired by <b>Square</b>) and <b>Affirm Holdings</b>&nbsp;demonstrating strong growth, and Visa has launched its own version as well.</p>\n<h2>Rewarding investors</h2>\n<p>At Monday's prices, Visa's stock has gained roughly 190% over the past five years, almost double the <b>S&amp;P 500</b> index. While it's trailing the broader market over the past year, it's still up nearly 15% as it's dealt with the weight of the pandemic. Its dividend yields 0.55% at the current price, well below the S&amp;P 500 average, but the company has raised its payout annually since 2008.</p>\n<p>Since it generally mirrors the state of the economy, which an overwhelming amount of the time expands rather than contracts, Visa is great long-term stock to own. Its top position makes it hard to compete with, and it can provide security and stability to a balanced portfolio.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why Visa Is One of the Best Long-Term Stocks to Buy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why Visa Is One of the Best Long-Term Stocks to Buy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-24 23:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/24/heres-why-visa-is-one-of-the-best-long-term-stocks/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you're like millions of people, you've already used your Visa (NYSE:V) card today. And that reach is what makes Visa stand out as a business investors want to be a part of.\nThe payment network took...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/24/heres-why-visa-is-one-of-the-best-long-term-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa"},"source_url":"https://www.fool.com/investing/2021/08/24/heres-why-visa-is-one-of-the-best-long-term-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161818081","content_text":"If you're like millions of people, you've already used your Visa (NYSE:V) card today. And that reach is what makes Visa stand out as a business investors want to be a part of.\nThe payment network took a big hit during the early stages of the pandemic, when consumer spending plunged. But it's rebounding along with the economy, and that's where its strength lies. As the largest credit card network in the world, it makes money whenever you swipe your card, making this blue-chip company a surefire bet for long-term growth.\nImage source: Getty Images.\nPowering payments\nVisa's network facilitates payments from consumers to merchants and takes a small fee from each transaction. The sheer number of people who use Visa credit cards demonstrates the company's dominance in the market -- there are currently 3.6 billion Visa cards in use, which translates into almost half the world's population. In 2019, Visa processed more than 200 billion transactions, or more than $11 trillion in volume.\nBecause Visa's model is a platform, it's a high-margin business that easily turns sales into profits. Operating margin was over 66% in Q3, and Visa turned $6.1 billion in revenue into $2.6 billion in net income. It also produced more than $4 billion in free cash flow, which it uses to grow its business as well as pay dividends and repurchase stock.\nBusiness plummeted during the height of pandemic restrictions, but the recovery is moving along. Revenue for the company's fiscal third quarter, covering the period ended June 30, increased 27% from the same period in 2020, but  10% over pre-pandemic 2019 levels.\nBecause the pandemic was such an outlier, we can see Visa's strength more clearly in its long-term growth. As of the latest quarter, Visa has grown revenue by a 9.5% compound annual growth rate (CAGR) over the past five years, and net income by an even better rate of 14.3%.\nFintech revolution\nOne of the ways Visa is protecting its top spot in credit card processing is acquiring and making deals with fintech partners. Its proposed acquisition of Plaid, a private company that connects financial apps with institutions, was scrapped after it was given a no-go by regulators. But it's made many smaller acquisitions to grow its business and especially to stay relevant as digital payments become more important. Most recently, it acquired Currencycloud, an app that simplifies foreign exchange to make cross-border payments easier. In Q3, it also announced that it would acquire Tink, a Swedish-based open banking platform.\nVisa needs to upgrade its systems as companies like PayPal Holdings make it easier to send and spend money digitally. Contactless payments are increasing in popularity, and in the U.S. alone Visa customers have more than 370 million tap-to-pay cards. Installment plans have also taken off, with companies such as Afterpay (recently acquired by Square) and Affirm Holdings demonstrating strong growth, and Visa has launched its own version as well.\nRewarding investors\nAt Monday's prices, Visa's stock has gained roughly 190% over the past five years, almost double the S&P 500 index. While it's trailing the broader market over the past year, it's still up nearly 15% as it's dealt with the weight of the pandemic. Its dividend yields 0.55% at the current price, well below the S&P 500 average, but the company has raised its payout annually since 2008.\nSince it generally mirrors the state of the economy, which an overwhelming amount of the time expands rather than contracts, Visa is great long-term stock to own. Its top position makes it hard to compete with, and it can provide security and stability to a balanced portfolio.","news_type":1,"symbols_score_info":{"AONE.U":0.9,"BOTB.UK":0.9,"V":0.9}},"isVote":1,"tweetType":1,"viewCount":1330,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835470370,"gmtCreate":1629735942190,"gmtModify":1633682812558,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Please help to like","listText":"Please help to like","text":"Please help to like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/835470370","repostId":"1198789813","repostType":4,"repost":{"id":"1198789813","kind":"news","pubTimestamp":1629729571,"share":"https://ttm.financial/m/news/1198789813?lang=&edition=full","pubTime":"2021-08-23 22:39","market":"us","language":"en","title":"Visa jumps into the NFT craze, buying a ‘CryptoPunk’ for $150,000","url":"https://stock-news.laohu8.com/highlight/detail?id=1198789813","media":"CNBC","summary":"KEY POINTS\n\nVisa said Monday it bought a “CryptoPunk,” one of thousands of NFT-based digital avatars","content":"<div>\n<p>KEY POINTS\n\nVisa said Monday it bought a “CryptoPunk,” one of thousands of NFT-based digital avatars, for nearly $150,000 in ethereum.\nAn NFT — which stands for non-fungible token — is a unique ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/23/visa-buys-cryptopunk-nft-for-150000.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Visa jumps into the NFT craze, buying a ‘CryptoPunk’ for $150,000</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVisa jumps into the NFT craze, buying a ‘CryptoPunk’ for $150,000\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-23 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/23/visa-buys-cryptopunk-nft-for-150000.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nVisa said Monday it bought a “CryptoPunk,” one of thousands of NFT-based digital avatars, for nearly $150,000 in ethereum.\nAn NFT — which stands for non-fungible token — is a unique ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/23/visa-buys-cryptopunk-nft-for-150000.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa"},"source_url":"https://www.cnbc.com/2021/08/23/visa-buys-cryptopunk-nft-for-150000.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1198789813","content_text":"KEY POINTS\n\nVisa said Monday it bought a “CryptoPunk,” one of thousands of NFT-based digital avatars, for nearly $150,000 in ethereum.\nAn NFT — which stands for non-fungible token — is a unique digital asset designed to represent ownership of a virtual item.\nCuy Sheffield, head of crypto at Visa, said NFTs will play an “important role” in the future of retail, social media and entertainment.\n\nVisa is the latest major company jumping into the NFT craze.\nThe payments processor said Monday it bought a “CryptoPunk,” one of thousands of NFT-based digital avatars, for nearly $150,000 in ethereum.\nAn NFT — which stands for non-fungible token — is a unique digital asset designed to represent ownership of a virtual item. Unlike bitcoin and other cryptocurrencies, NFTs can’t be exchanged like-for-like with another NFTs.\nProponents say this makes NFTs scarce, driving up their value. NFTs have often been compared to physical collectible items like rare trading cards and works of art.\n“We think NFTs will play an important role in the future of retail, social media, entertainment, and commerce,” Cuy Sheffield, head of crypto at Visa, said in a blogpost Monday.\n“To help our clients and partners participate, we need a firsthand understanding of the infrastructure requirements for a global brand to purchase, store, and leverage an NFT.”\nSheffield said CryptoPunks have become a “cultural icon for the crypto community.”\n“With our CryptoPunk purchase, we’re jumping in feet first,” he said. “This is just the beginning of our work in this space.”\nAnchorage, a federally-chartered digital asset bank, facilitated the purchase, Visa said.\nBig firms join NFT craze\nSeveral big firms have been experimenting with NFTs lately.\nChristie’s has auctioned off several NFTs, some worth millions of dollars. The auction house set records in March when an image created by the digital artist Beeple sold for $69 million.\nMeanwhile, a number of media publications, including CNN, The New York Times and Fortune magazine, have sold NFTs of their own.\nBut some critics are skeptical of NFTs. While such tokens represent a digital certificate of ownership, buyers don’t own the underlying item, and internet users can still view the associated media online. Some people have even stolen other artists’ work and gone on to sell them as NFTs.\n“The purchaser of Beeple’s $69 million NFT artwork, ‘Everydays – The First 5000 Days’, owns the unique token,” Adam Rendle, partner at law firm Taylor Wessing, said in a blogpost.\n“They do not, however, own copyright or any other intellectual property rights in the digital artwork itself. They cannot distribute or otherwise commercialise the represented asset.”","news_type":1,"symbols_score_info":{"V":0.9}},"isVote":1,"tweetType":1,"viewCount":1838,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":832955495,"gmtCreate":1629567875117,"gmtModify":1633684015904,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Great news. Please help to like","listText":"Great news. Please help to like","text":"Great news. Please help to like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/832955495","repostId":"2161745179","repostType":4,"isVote":1,"tweetType":1,"viewCount":1538,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897333477,"gmtCreate":1628877095199,"gmtModify":1633688806393,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Will take a look","listText":"Will take a look","text":"Will take a look","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/897333477","repostId":"2159291893","repostType":4,"repost":{"id":"2159291893","kind":"highlight","pubTimestamp":1628864400,"share":"https://ttm.financial/m/news/2159291893?lang=&edition=full","pubTime":"2021-08-13 22:20","market":"us","language":"en","title":"2 Tech Stocks With 96% to 140% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2159291893","media":"Motley Fool","summary":"Analysts see big gains for Coinbase and Lemonade shareholders.","content":"<p>As a long-term investor, I tend to ignore near-term price targets. Instead, I look for stocks I can hold for at least five years, and preferably longer if my investment thesis remains intact. That being said, price targets can be a good place to find inspiration, and there's no harm in glancing at these figures -- provided you do your own research, too.</p>\n<p>With that in mind, Wall Street analysts see significant upside for&nbsp;<b>Coinbase Global</b> (NASDAQ:COIN) and&nbsp;<b>Lemonade</b> (NYSE:LMND). Let's look at both of these tech stocks.</p>\n<h2>Coinbase Global: 140% implied upside</h2>\n<p>Coinbase helps its clients participate in the cryptoeconomy. Its platform offers a range&nbsp;of products to 68 million&nbsp;users, including retail investors, financial institutions, and ecosystem partners. Of course, brokerage services are the core business, but there's a lot more to Coinbase.</p>\n<p>For instance, its platform also allows individuals to send, spend, borrow, and lend cryptocurrency, and it offers a cold storage solution to institutional clients. Coinbase also provides blockchain analytics tools to law enforcement, application-building tools to developers, and payment processing tools to merchants.</p>\n<p>As of the most recent quarter, Coinbase had $180 billion in assets on its platform, or 11.2%&nbsp;of all crypto assets, making it the market leader. That immense scale demonstrates the company's trusted brand, and it creates an opportunity for further monetization. With those advantages in mind, analysts at D.A. Davidson&nbsp;value Coinbase stock at $650 per share, a 140% premium to its current price.</p>\n<p>Financially, Coinbase is growing at a shocking pace -- but investors should consider these metrics with caution. Transaction fees&nbsp;comprise the vast majority of revenue, and those fees depend on trading volume, which has historically been highly correlated with the price&nbsp;of <b>bitcoin</b> and the volatility of crypto assets. And so far this year, the crypto market has been incredibly volatile, juicing monthly transacting users and revenue.</p>\n<table>\n <thead>\n  <tr>\n   <th><p>Metric</p></th>\n   <th><p>Q2 2020 (TTM)</p></th>\n   <th><p>Q2 2021 (TTM)</p></th>\n   <th><p>CAGR</p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td width=\"156\"><p>Monthly transacting users</p></td>\n   <td width=\"156\"><p>1.5 million</p></td>\n   <td width=\"156\"><p>8.8 million</p></td>\n   <td width=\"156\"><p>487%</p></td>\n  </tr>\n  <tr>\n   <td width=\"156\"><p>Revenue</p></td>\n   <td width=\"156\"><p>$633.8 million</p></td>\n   <td width=\"156\"><p>$4.9 billion</p></td>\n   <td width=\"156\"><p>678%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Data source: Coinbase&nbsp;SEC filings. TTM&nbsp;= trailing-12-months. CAGR&nbsp;= compound annual growth rates.</p>\n<p>Before buying Coinbase stock, investors should ask themselves <a href=\"https://laohu8.com/S/AONE.U\">one</a> question: Is cryptocurrency here to stay? If you think the answer is no, forget this stock. But if you see a future for cryptocurrency -- either as a store of value or a transactional medium -- then Coinbase could be a good way to tap into that trend.</p>\n<h2>Lemonade: 96% implied upside</h2>\n<p>Lemonade is a tech company that's disrupting the $5 trillion insurance industry. Specifically, the company uses big data and artificial intelligence to manage many aspects of its business, from quantifying risk and underwriting policies to processing claims and engaging clients.</p>\n<p>This differentiates it from traditional insurance providers, the vast majority of which rely on human brokers and agents. More to the point, many of today's industry leaders were founded over a century ago, long before the digital era, and their businesses simply weren't built&nbsp;to collect and deploy the types of data captured by Lemonade.</p>\n<p>This advantage should make Lemonade's platform faster, cheaper, and more precise over time, creating a flywheel effect that strengthens as the company adds more clients. With that in mind, analysts at Piper Sandler&nbsp;value Lemonade at $163 per share, representing 96% upside compared to its current price.</p>\n<p>Investors shouldn't fool themselves -- disrupting a well-established industry is rarely easy, and Lemonade has a long road ahead. However, the company's early financial results show promise. In Q2 2021, in-force premium (i.e. the annualized sum of customer premiums) reached $296.8 million, up 312% from Q2 2019. Over the same period, Lemonade has added new customers quickly, driving strong growth in gross profit.</p>\n<table>\n <thead>\n  <tr>\n   <th><p>Metric</p></th>\n   <th><p>Q2 2019 (TTM)</p></th>\n   <th><p>Q2 2021 (TTM)</p></th>\n   <th><p>CAGR</p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td width=\"156\"><p>Customers</p></td>\n   <td width=\"156\"><p>442,752</p></td>\n   <td width=\"156\"><p>1.2 million</p></td>\n   <td width=\"156\"><p>65%</p></td>\n  </tr>\n  <tr>\n   <td width=\"156\"><p>Gross profit</p></td>\n   <td width=\"156\"><p>$5.7 million</p></td>\n   <td width=\"156\"><p>$26.5 million</p></td>\n   <td width=\"156\"><p>116%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Data source: Lemonade SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rate.</p>\n<p>Looking ahead, investors should pay attention to Lemonade's gross loss ratio (i.e. the percentage of premiums paid out in claims). This metric assesses how effectively an insurance company estimates risk and prices policies. For reference, Lemonade aims to keep its average loss ratio below 75% on a multi-year basis. If that number starts trending the wrong direction, it could be a red flag.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Tech Stocks With 96% to 140% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Tech Stocks With 96% to 140% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-13 22:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/13/tech-stocks-96-to-140-upside-wall-street-coinbase/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As a long-term investor, I tend to ignore near-term price targets. Instead, I look for stocks I can hold for at least five years, and preferably longer if my investment thesis remains intact. That ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/13/tech-stocks-96-to-140-upside-wall-street-coinbase/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LMND":"Lemonade, Inc.","COIN":"Coinbase Global, Inc."},"source_url":"https://www.fool.com/investing/2021/08/13/tech-stocks-96-to-140-upside-wall-street-coinbase/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159291893","content_text":"As a long-term investor, I tend to ignore near-term price targets. Instead, I look for stocks I can hold for at least five years, and preferably longer if my investment thesis remains intact. That being said, price targets can be a good place to find inspiration, and there's no harm in glancing at these figures -- provided you do your own research, too.\nWith that in mind, Wall Street analysts see significant upside for Coinbase Global (NASDAQ:COIN) and Lemonade (NYSE:LMND). Let's look at both of these tech stocks.\nCoinbase Global: 140% implied upside\nCoinbase helps its clients participate in the cryptoeconomy. Its platform offers a range of products to 68 million users, including retail investors, financial institutions, and ecosystem partners. Of course, brokerage services are the core business, but there's a lot more to Coinbase.\nFor instance, its platform also allows individuals to send, spend, borrow, and lend cryptocurrency, and it offers a cold storage solution to institutional clients. Coinbase also provides blockchain analytics tools to law enforcement, application-building tools to developers, and payment processing tools to merchants.\nAs of the most recent quarter, Coinbase had $180 billion in assets on its platform, or 11.2% of all crypto assets, making it the market leader. That immense scale demonstrates the company's trusted brand, and it creates an opportunity for further monetization. With those advantages in mind, analysts at D.A. Davidson value Coinbase stock at $650 per share, a 140% premium to its current price.\nFinancially, Coinbase is growing at a shocking pace -- but investors should consider these metrics with caution. Transaction fees comprise the vast majority of revenue, and those fees depend on trading volume, which has historically been highly correlated with the price of bitcoin and the volatility of crypto assets. And so far this year, the crypto market has been incredibly volatile, juicing monthly transacting users and revenue.\n\n\n\nMetric\nQ2 2020 (TTM)\nQ2 2021 (TTM)\nCAGR\n\n\n\n\nMonthly transacting users\n1.5 million\n8.8 million\n487%\n\n\nRevenue\n$633.8 million\n$4.9 billion\n678%\n\n\n\nData source: Coinbase SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rates.\nBefore buying Coinbase stock, investors should ask themselves one question: Is cryptocurrency here to stay? If you think the answer is no, forget this stock. But if you see a future for cryptocurrency -- either as a store of value or a transactional medium -- then Coinbase could be a good way to tap into that trend.\nLemonade: 96% implied upside\nLemonade is a tech company that's disrupting the $5 trillion insurance industry. Specifically, the company uses big data and artificial intelligence to manage many aspects of its business, from quantifying risk and underwriting policies to processing claims and engaging clients.\nThis differentiates it from traditional insurance providers, the vast majority of which rely on human brokers and agents. More to the point, many of today's industry leaders were founded over a century ago, long before the digital era, and their businesses simply weren't built to collect and deploy the types of data captured by Lemonade.\nThis advantage should make Lemonade's platform faster, cheaper, and more precise over time, creating a flywheel effect that strengthens as the company adds more clients. With that in mind, analysts at Piper Sandler value Lemonade at $163 per share, representing 96% upside compared to its current price.\nInvestors shouldn't fool themselves -- disrupting a well-established industry is rarely easy, and Lemonade has a long road ahead. However, the company's early financial results show promise. In Q2 2021, in-force premium (i.e. the annualized sum of customer premiums) reached $296.8 million, up 312% from Q2 2019. Over the same period, Lemonade has added new customers quickly, driving strong growth in gross profit.\n\n\n\nMetric\nQ2 2019 (TTM)\nQ2 2021 (TTM)\nCAGR\n\n\n\n\nCustomers\n442,752\n1.2 million\n65%\n\n\nGross profit\n$5.7 million\n$26.5 million\n116%\n\n\n\nData source: Lemonade SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rate.\nLooking ahead, investors should pay attention to Lemonade's gross loss ratio (i.e. the percentage of premiums paid out in claims). This metric assesses how effectively an insurance company estimates risk and prices policies. For reference, Lemonade aims to keep its average loss ratio below 75% on a multi-year basis. If that number starts trending the wrong direction, it could be a red flag.","news_type":1,"symbols_score_info":{"COIN":0.9,"LMND":0.9}},"isVote":1,"tweetType":1,"viewCount":720,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}